Manufacturing news briefs – stories you might have missed

FDA accepts Mesoblast’s responses  Biotech company Mesoblast has announced that the United States Food and Drug Administration (FDA) has accepted Mesoblast’s Biologics License Application (BLA) resubmission for Ryoncil (remestemcel-L) in the treatment of children with steroid-refractory acute graft versus host disease (SR-aGVHD). According to a statement, the FDA considers the resubmission to be a complete…

Government focus on defence innovation – Thistlethwaite

The Assistant Minister for defence Matt Thistlethwaite has spruiked the government’s response to the Defence Strategic Review in the field of defence innovation, including through joint work with AUKUS partners the US and the UK. The DSR found that more support is needed for innovation, faster acquisition and better links between Defence and industry to…